Internal Medicine, Infectious Disease · Naples, FL
NPI
1316095565
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
800 Goodlette Rd N Ste 370
Naples, FL, 34102
Phone (239) 624-0800
Groups this clinician bills Medicare through
Medicare paid, 2024
$249K
2,504 services
Medicare patients, 2024
982
Average age 78
Drug cost, 2024
$1.2M
1,074 prescriptions
Company payments, 2025
$929
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sergey P Akimov was code 99233 (hospital e&m - subsequent), 1,351 times for 552 patients. In total Sergey P Akimov billed 2,504 services in 11 codes, and Medicare paid $249K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 1,351 | 552 | $93.88 | $127K |
| 99214 Office E&M - Established | Office | 457 | 305 | $95.62 | $44K |
| 99223 Hospital E&M - Initial | Facility | 415 | 399 | $136.88 | $57K |
| 99232 Hospital E&M - Subsequent | Facility | 125 | 107 | $62.16 | $7,771 |
| 99213 Office E&M - Established | Office | 72 | 66 | $58.41 | $4,206 |
| 99204 Office E&M - New | Office | 46 | 46 | $127.17 | $5,850 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 11 | 11 | $42.92 | $472 |
By year: 2022 $755K for 95,354 services; 2023 $256K for 2,486 services; 2024 $249K for 2,504 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 101 | 82 | $2.97 | $300 |
Medicare prescription drug claims, 2024
In 2024, the drug Sergey P Akimov prescribed most often to Medicare patients was Ceftriaxone (Ceftriaxone Sodium), with 87 prescriptions and refills. In total Sergey P Akimov wrote 1,074 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ceftriaxone Ceftriaxone Sodium | 87 | 87 | 23 | $5,816 |
| Daptomycin Generic | 81 | 81 | 23 | $47K |
| Azithromycin Generic | 66 | 104 | 28 | $1,940 |
| Ertapenem Ertapenem Sodium | 58 | 58 | 16 | $27K |
| Ethambutol Hcl Generic | 57 | 81 | 21 | $3,016 |
| Doxycycline Hyclate Generic | 53 | 61 | 32 | $1,331 |
| Levofloxacin Generic | 51 | 65 | 35 | $732 |
| Rifampin Generic | 48 | 67 | 17 | $2,407 |
| Fluconazole Generic | 43 | 55 | 30 | $773 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 33 | 51 | 18 | $1,179 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 28 | 32 | 17 | $327 |
| Arikayce Amikacin Liposomal/Neb.Accessr | 26 | 26 | Under 11 | $387K |
| Nuzyra Omadacycline Tosylate | 23 | 23 | Under 11 | $358K |
| Cefadroxil Generic | 22 | 40 | 12 | $960 |
| Amoxicillin Generic | 22 | 26 | Under 11 | $283 |
Brand drugs: 141 claims; generic drugs: 933 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sergey P Akimov $929 ($929 in general payments such as food, travel and fees) from 11 companies. The largest payer was Gilead Sciences, Inc. with $335.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 13 | $335 |
| Insmed, Inc. INSM | 12 | $148 |
| Paratek Pharmaceuticals, Inc. | 6 | $130 |
| ViiV Healthcare Company GSK | 3 | $74.15 |
| Abbvie Inc. ABBV | 2 | $53.05 |
| Aimmune Therapeutics, Inc. | 3 | $41.01 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $30.84 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $30.52 |
| La Jolla Pharmaceutical Company | 1 | $29.99 |
| CSL Behring CSL.AX | 1 | $29.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.